Web-Books
im Austria-Forum
Austria-Forum
Web-Books
Medizin
Advances in Neuroimmunology
Seite - 56 -
  • Benutzer
  • Version
    • Vollversion
    • Textversion
  • Sprache
    • Deutsch
    • English - Englisch

Seite - 56 - in Advances in Neuroimmunology

Bild der Seite - 56 -

Bild der Seite - 56 - in Advances in Neuroimmunology

Text der Seite - 56 -

BrainSci. 2016,6, 41 Fractalkine isaproteinexpressedconstitutivelybyneurons inamembraneboundformthatcan becleavedbydisintegrinandmetalloproteinase(ADAM)10and17.Thisproteolysisreleasesasoluble formoftheprotein,butbothisoformsarethoughtto ligate thecognatereceptor,CX3CR1, locatedonthe surfaceofmicroglia in theCNS[42]. Thisneuron-glia interactionservesasan importantendogenous mechanismtosuppressmicroglialactivationandregulatetheoutputofinflammatorymediatorsandother damagingmolecules[42]. IthasbeenshownthatincreasingfractalkinelevelsusinganAAV9genetherapy approachcanbeneuroprotective[35,36],whiletheabsenceofthisFKN-CX3CR1signalingcascadeconfers susceptibility toneurodegeneration in rodentmodels of PD.Cardonaetal. (2006) demonstrated that CX3CR1deficiencyleadtoincreaseneurotoxicitytobothperipheralLPSandMPTPinjections. Inthese experiments,bothheterozygousandhomozygousmiceexhibitedincreasedneurodegenerationandIL-1β expressioncomparedtotheintactwild-typecontrols [43]. Thereisevidenceindicatingthatfractalkinecan regulatemicroglial functionandsubsequentlyreduceinflammationintheCNS.Multiple invitrostudies haveestablishedthatenhancingfractalkinesignalingthroughapplicationof the ligandorstimulation of the receptor canprotect against cell death in culture; FKN-liganddecreasesmicroglial apoptosis andprotectsagainstneurotoxicitybybothLPSandTNF-α. Ithasbeendemonstratedthatmaintaining or enhancing communication of FKN/CX3CR1 is neuroprotective inmultiple rodentmodels of PD. Pabonetal. (2011) [37]attenuatedtheneurotoxicityof6hydroxydopamine(6OHDA)bydelivering achronic intrastriatal infusionofrecombinant fractalkine ligand. Thispreservationofdopaminergic terminals in thestriatumwasalsoassociatedwithdecreasedmicroglialactivationaroundthe lesion site, indicatedbyareducedexpressionof theMHCIIsurfacemarker. Tofurtherexaminetheaction of fractalkine inamodelofPDwheresynuclein is introduced in theSNviaAAV,Nashetal. (2015) corroboratedtheneuroprotectiveeffectsofFKNbyusingaviralvector tooverexpress thedifferent isoformsofFKN;membrane-bound(mFKN)orthesolubleportion(sFKN).Inthisstudy,sFKNreduced DAcell death in young ratswith overexpressionα-syn in the SNviaAAV9. Thesefindingsmay bedue toalteredFKN-CX3CR1signaling [44] anda reduction inpro-inflammatory cytokines and modulationofmicroglial function intoamoreprotective role (Figure1). These results suggest that supraphysiological levelsof the fractalkineareprotectiveagainst theneurodegenerationoccurring in twoseparateexperimentalmodelsofPD.Morgantietal. (2012) [36]also illustratedthe importance ofneuron-glial communicationbyadministeringMPTPtoanimalsdeficient in the fractalkine ligand. TheseFKNknockoutswereextremelysusceptible toMPTPtoxicity,anddisplaybothadramatic loss ofTHintheSNandtherobustgliosisassociatedwith the lesionsite.Notonlydoes thiswork indicate thatFKN-CX3CR1communication isnecessary formoderatingcelldeathandsubsequentdetrimental inflammatory events, but it also suggests that further enhancing or supplementing this signaling pathwayabovebaselineactivity is sufficient toachieveneuroprotectionagainst thesepotent toxins (Figure1). However, theactionof fractalkine isquite complex;CX3CR1knockoutmicehavebeen shownto increasephagocytosisofamyloid,butdecreasephagocytosisof synuclein [44]. It isunclear if thisaction ismediatedbymembraneboundfractalkineor thecleaved, soluble form. Several studies have triedtoclarify therolesof thedifferentialprocessingof fractalkineandtheredoesnotappear to beaclearconclusionat thispoint.Whenanobligatesolubleversionof fractalkine isused,asdescribed herewithagene therapyapproach, ithasbeenshowntobebeneficial inmodelsofPDandADtau pathology[35,36,45].However, inothermodelswhereanobligatesoluble fractalkinemouse isused, oppositeresultshavebeenobserved,andthispaperconcludesthat themembraneanchoredfractalkine isassociatedwithphagocytosisofAβ [46]. Much of the current data regarding the therapeutic potential of FKN in the treatment of inflammatoryandneurodegenerativeconditionsstemsfromstudiesinvolvingyounganimals.However, it is essential to note that aged microglia have been shown to be resistant to their regulatory signals [20,47]. Furthermore,communicationvia theFKN/CX3CR1axisbecomesdysregulatedwith ageandcanalsocontribute tomicroglialpriminganddysfunction. Thereareageassociatedchanges affectingboth the ligandand receptor. It has beenhas shown that FKN is reducedby in the aged hippocampus [48], although the extent of FKN downregulation in the SN has not yet been fully 56
zurück zum  Buch Advances in Neuroimmunology"
Advances in Neuroimmunology
Titel
Advances in Neuroimmunology
Autor
Donna Gruol
Herausgeber
MDPI
Ort
Basel
Datum
2017
Sprache
englisch
Lizenz
CC BY-NC-ND 4.0
ISBN
978-3-03842-571-7
Abmessungen
17.0 x 24.0 cm
Seiten
164
Schlagwörter
neuroimmune, cytokine, chemokine, glia cel, neuron, neurodevelopment, neuroimmune disorder, neurologic disease, psychiatric disease, neuronal injury
Kategorie
Medizin
Web-Books
Bibliothek
Datenschutz
Impressum
Austria-Forum
Austria-Forum
Web-Books
Advances in Neuroimmunology